Pete Chan

Head of Research for @xperiome. Advocate of #raredisease research. Ex-Scrip 100 Editor. Interested in all things disruptive in health & tech.

[Elizabeth Alker @elizabethalker]

It's true, I do!

[Raremark @RaremarkHealth]

Here are some of the latest research projects we're working on. Sign up to our newsletter to see what we find: https://t.co/EF7vPcnlBB

[Tim Davis @digital_timd]

Some thoughts from me on the impact of #coronavirus on #clinicaltrials https://t.co/N94gLF5tGJ

[PharmaTimes @PharmaTimes]

This Rare Disease Day, PharmaTimes talks to @RaremarkHealth's Pete Chan about the myriad of stakeholders that make up the rare disease ecosystem: https://t.co/3uiVMuPuJI

[Raremark @RaremarkHealth]

#RareDiseaseDay - We’re posting stories on all our community pages today, highlighting how more than 300 million people are living with rare disease. “Rare is many. Rare is strong. Rare is proud.” @Rare Disease Day

[Jules Walters @julesawalters]

Reaching those with a rare medical condition to move forward research requires a different approach @RaremarkHealth in @ContractPharma https://t.co/FOskWhuu6u

[Pete Chan @PeteChan100]

Rare Disease Day is a much-needed fixture in the calendar, but the job of delivering new treatments cannot be achieved in a big-bang, once-a-year burst of activity https://t.co/UT5vjMNQxr #RareDiseaseDay #rarediseaseday2020

[Raremark @RaremarkHealth]

Raremark announces new appointments.
Industry experts Neil Rotherham, Tim Davis and Jeremy Edwards have been appointed as Chairman, Chief Executive Officer and Chief Commercial Officer, to help the company accelerate progress in rare disease research.

https://t.co/GNl4ufLRYu

[Pete Chan @PeteChan100]

A novel pricing mechanism might help payers warm to pricey, ultra-orphan drugs: https://t.co/jpvnBtIyCj

[Pete Chan @PeteChan100]

Story of a rare disease patient turned doctor turned drug-discovery innovator: https://t.co/TBFgzMZlqn

[Raremark @RaremarkHealth]

Raremark collaborated with Alex, The Leukodystrophy Charity (formerly ALD Life) to reveal the true impact of adrenomyeloneuropathy on people living with the condition. This is what we found.@alexTLCsupport

#leukodystrophy #raredisease
https://t.co/2S5S2xPxsY

[Pete Chan @PeteChan100]

@ByMadeleineA @ZacharyBrennan @ByJonGardner This is what I made of it all (with some help from Evaluate data): https://t.co/skm1BYkBHl

[Ataxia_aware CIO 1184030 (previously Ataxia_and_me @Ataxia_aware]

Thank you @PeteChan100 @RaremarkHealth for being #Ataxia aware

#RAREsummit19

[Raremark @RaremarkHealth]

Raremark’s Pete Chan, Head of Research and Analysis, participated in a moderated discussion on patients at the heart of AI at #RAREsummit19 hosted by #camraredisease #raredisease #patientsfirst #rareheroes https://t.co/yi7cOM6q9O

[Pete Chan @PeteChan100]

Determined minister kicks off @camraredisease hackathon #RAREsummit19 @RaremarkHealth

[Ataxia_aware CIO 1184030 (previously Ataxia_and_me @Ataxia_aware]

Second panel @camraredisease #RareSummit19
Including
Tïm @healx
Pete @PeteChan100 @RaremarkHealth
Elin @elinhafdavies @aparitohealth
#RareDisease #DigitalHealth

[Jules Walters @julesawalters]

With #alaneverywhere @ataxiaandme #wodeurope spreading the word about the patient journey in Ataxia - always a pleasure

[Larissa Kerecuk @BCH_Rare]

Moving patient stories of delay in diagnosis in Fabry’s by @PeteChan100 @Rarebaseltd

[Larissa Kerecuk @BCH_Rare]

Great to hear @PeteChan100 @RaremarkHealth @Rarebaseltd conference on diagnostic odyssey: working to reduce time to diagnosis 👍👏

[Pete Chan @PeteChan100]

“The AI conversation in healthcare desperately needs a reality check” & other snippets from Rock Health Summit https://t.co/M5HGitG5q2